Recent Acquisition Science 37 was recently acquired by eMed LLC for $38 million, indicating potential opportunities to align with the new parent company's network and leverage their resources for increased sales and market penetration.

Recognition and Awards Having been recognized as a leader in decentralized clinical trials by Everest Group for three consecutive years, Science 37's strong reputation and credibility can be leveraged to attract new clients seeking innovative and reliable research services.

Strategic Partnerships Through partnerships with organizations like Citeline Connect and SCRS, Science 37 has expanded its reach and patient recruitment capabilities. Leveraging these partnerships can open doors to collaborative sales opportunities and accessing new markets.

Technology Stack Utilizing advanced technologies such as AWS Lambda, Docker, and iOS, Science 37 demonstrates a commitment to innovation and efficiency in clinical research services. Leveraging their tech stack as a selling point can resonate with tech-savvy clients looking for modern solutions.

Market Presence With a revenue ranging between $100 million to $1 billion and a workforce of 501-1000 employees, Science 37 holds a strong position in the highly competitive research services industry. This market presence offers opportunities to showcase stability and expertise to potential clients seeking established partners.